Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Beg

Showing results (311-320 of 340) with videos related to

Pageof 34
Sort By:
HGG Advances|July 3, 2024
A model organism pipeline provides insight into the clinical heterogeneity of TARS1 loss-of-function variantsRebecca Meyer-Schuman, Allison R Cale, Jennifer A Pierluissi, et al.
Biorxiv : the Preprint Server for Biology|April 8, 2024
Predictive modeling provides insight into the clinical heterogeneity associated with <i>TARS1</i> loss-of-function mutationsRebecca Meyer-Schuman, Allison R Cale, Jennifer A Pierluissi, et al.
BMC Genomics|October 22, 2016
Spontaneous preterm birth and single nucleotide gene polymorphisms: a recent updateIshfaq A Sheikh, Ejaz Ahmad, Mohammad S Jamal, et al.
Cancer Immunology Research|February 9, 2023
Combination IFNβ and Membrane-Stable CD40L Maximize Tumor Dendritic Cell Activation and Lymph Node Trafficking to Elicit Systemic T-cell ImmunityHong Zheng, Xiaoqing Yu, Mohammed L Ibrahim, et al.
Scientific Reports|June 25, 2024
Manufacturing and preclinical toxicity of GLP grade gene deleted attenuated Leishmania donovani parasite vaccineKumar Avishek, Mirza A Beg, Kavita Vats, et al.
Blood|August 3, 2013
Pharmacologic inhibition of PKCα and PKCθ prevents GVHD while preserving GVL activity in miceKelley M K Haarberg, Jun Li, Jessica Heinrichs, et al.
The Journal of Clinical Investigation|November 13, 2009
PKCtheta is required for alloreactivity and GVHD but not for immune responses toward leukemia and infection in miceJavier O Valenzuela, Cristina Iclozan, Mohammad S Hossain, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 12, 2016
HDAC Inhibitors Enhance T-Cell Chemokine Expression and Augment Response to PD-1 Immunotherapy in Lung AdenocarcinomaHong Zheng, Weipeng Zhao, Cihui Yan, et al.
Cancer Cell|November 22, 2024
Interleukin-1α release during necrotic-like cell death generates myeloid-driven immunosuppression that restricts anti-tumor immunityKay Hänggi, Jie Li, Achintyan Gangadharan, et al.
Molecular Biology and Evolution|June 5, 2013
The evolutionary history of Plasmodium vivax as inferred from mitochondrial genomes: parasite genetic diversity in the AmericasJesse E Taylor, M Andreína Pacheco, David J Bacon, et al.
Pageof 34

Showing results (311-320 of 340) with videos related to

Sort By:
Pageof 34
HGG Advances|July 3, 2024
A model organism pipeline provides insight into the clinical heterogeneity of TARS1 loss-of-function variantsRebecca Meyer-Schuman, Allison R Cale, Jennifer A Pierluissi, et al.
Biorxiv : the Preprint Server for Biology|April 8, 2024
Predictive modeling provides insight into the clinical heterogeneity associated with <i>TARS1</i> loss-of-function mutationsRebecca Meyer-Schuman, Allison R Cale, Jennifer A Pierluissi, et al.
BMC Genomics|October 22, 2016
Spontaneous preterm birth and single nucleotide gene polymorphisms: a recent updateIshfaq A Sheikh, Ejaz Ahmad, Mohammad S Jamal, et al.
Cancer Immunology Research|February 9, 2023
Combination IFNβ and Membrane-Stable CD40L Maximize Tumor Dendritic Cell Activation and Lymph Node Trafficking to Elicit Systemic T-cell ImmunityHong Zheng, Xiaoqing Yu, Mohammed L Ibrahim, et al.
Scientific Reports|June 25, 2024
Manufacturing and preclinical toxicity of GLP grade gene deleted attenuated Leishmania donovani parasite vaccineKumar Avishek, Mirza A Beg, Kavita Vats, et al.
Blood|August 3, 2013
Pharmacologic inhibition of PKCα and PKCθ prevents GVHD while preserving GVL activity in miceKelley M K Haarberg, Jun Li, Jessica Heinrichs, et al.
The Journal of Clinical Investigation|November 13, 2009
PKCtheta is required for alloreactivity and GVHD but not for immune responses toward leukemia and infection in miceJavier O Valenzuela, Cristina Iclozan, Mohammad S Hossain, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 12, 2016
HDAC Inhibitors Enhance T-Cell Chemokine Expression and Augment Response to PD-1 Immunotherapy in Lung AdenocarcinomaHong Zheng, Weipeng Zhao, Cihui Yan, et al.
Cancer Cell|November 22, 2024
Interleukin-1α release during necrotic-like cell death generates myeloid-driven immunosuppression that restricts anti-tumor immunityKay Hänggi, Jie Li, Achintyan Gangadharan, et al.
Molecular Biology and Evolution|June 5, 2013
The evolutionary history of Plasmodium vivax as inferred from mitochondrial genomes: parasite genetic diversity in the AmericasJesse E Taylor, M Andreína Pacheco, David J Bacon, et al.
Pageof 34